Electrochemical pump for drug delivery and drug delivery device

The innovative electrochemical pump design with separated electrodes and improved geometry addresses efficiency and control issues, ensuring stable drug delivery with reduced impedance and corrosion, enhancing precision and comfort.

JP2024544490AActive Publication Date: 2024-12-03MICROMED CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2024525976
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-02
Filing Date
2022-11-02
Publication Date
2024-12-03
Estimated Expiration
2042-11-02

AI Technical Summary

Technical Problem

Existing electrochemical pumps for drug delivery face issues such as high impedance and low local electric field, leading to high power losses and low solid state free energy, electrode corrosion due to shared contact pads, and difficulty in accurately controlling drug delivery speed and volume, especially for viscous drugs and large doses.

Method used

The design separates electrodes and contact pads on opposite sides of the substrate, uses a hydrophilic layer and superabsorbent material to enhance electrochemical efficiency, and employs a removable electronic device with improved electrode geometry and through-hole connections for efficient energy transfer.

Benefits of technology

This configuration reduces impedance, prevents corrosion, and enhances control precision, allowing for stable drug delivery at varying speeds and volumes, minimizing patient discomfort.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024544490000001_ABST
    Figure 2024544490000001_ABST
Patent Text Reader

Abstract

The present disclosure provides an electrochemical pump and a drug delivery device for drug delivery. The electrochemical pump includes a substrate including a first surface, a second surface, and a plurality of through holes, a plurality of electrodes, an electronic device, and an electrolyte-containing space. The second surface has a plurality of contacts, and the through holes have a conductive material therein and are electrically connected to the plurality of contacts. The plurality of electrodes are disposed on the first surface and are electrically connected to the plurality of contacts on the second surface via the conductive material inside the plurality of through holes. The electronic device is disposed on the second surface and is electrically connected to the contacts on the second surface. The electrolyte-containing space includes an electrolyte therein and is adjacent to the first surface such that the plurality of electrodes are in contact with the electrolyte. The present disclosure also provides a drug delivery device implementing the electrochemical pump.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to electrochemical pumps and drug delivery devices for use in the automated delivery of drugs. [Background technology]

[0002] Recently, the pharmaceutical industry believes that electrochemical pump technology for delivering therapeutic drugs has room for further development and improvement. However, the design of electrochemical pumps traditionally used for delivering therapeutic drugs has deficiencies that need to be improved. For example, in electrochemical pumps using microelectrode structures, the electrolyte has high impedance and low local electric field, which not only results in high power loss, but also low solid free energy at the electrode surface. All of the above causes the problem of high power consumption of the entire pump system.

[0003] In addition, the electrodes and contact pads of the conventional electrochemical pump are usually located on the same side of the substrate, so that the connection material between the control circuit substrate and the electrodes is inevitably corroded by the electrochemical electrolyte during the electrochemical reaction, which seriously affects the operation and energy consumption of the entire electrochemical pump system. Summary of the Invention [Problem to be solved by the invention]

[0004] The working mechanism of electrochemical drug delivery medical devices is mainly by generating gas pressure as a driving force source. For example, the pressure difference between the inside of the drug delivery device and the surrounding environment of the device is used to deliver drugs. However, in order to accurately control the magnitude of the pressure generated in the device, advanced device structure design and electronic control device design are required, and if the design is not appropriate, it may be difficult to accurately control the amount of gas generated to accurately control the small amount of drug and stabilize the delivery speed of the drug.

[0005] In addition, when the drug delivery device is required to drive a highly viscous drug at an ultra-high speed, the output of the electrochemical device must be increased accordingly, and it must be capable of outputting a very large driving force. Therefore, the circuit board and the power supply must also be capable of outputting a very high output energy. If the contact pad and the electrode are designed to be on the same side, the lead part between the contact pad and the electrode will greatly increase the overall resistance impedance, which will seriously affect the loss of energy transmitted from the power supply to the electrode, and will greatly reduce the pressure output performance of the entire electrochemical pump system.

[0006] In addition, when a large amount (e.g., several milliliters) of a highly concentrated drug needs to be delivered by subcutaneous or intramuscular injection, a gentler injection speed and a slightly longer injection time should be adopted to avoid the problem of patient pain caused by too fast injection. When injection delivery is performed manually, not only is labor cost high, but it is also difficult to accurately control the drug delivery speed to avoid the above-mentioned pain problem. Currently, the mainstream of commercially available automatic delivery devices use mechanical force (such as a spring) or a micromotor as the delivery source. However, the unstable delivery force of a spring or micromotor may cause unexpected pain during injection, and it is difficult to achieve both high delivery speed and stability.

[0007] Therefore, there is an urgent need to develop an electrochemical pump structure that improves or resolves the above problems in the field and avoids corrosion due to the electrodes and lead pads being located on the same side, as well as a miniaturized automated drug delivery device or method that reduces impedance to increase the efficiency of energy delivery and improves the control accuracy of energy delivery to reduce pain. [Means for solving the problem]

[0008] In order to achieve the object of the present invention, the present disclosure provides an electrochemical pump for drug delivery and a drug delivery device thereof. The electrochemical pump includes a substrate, a plurality of electrodes, an electronic device, and an electrolyte receiving space. The substrate has a first surface, a second surface, and a plurality of through holes, the second surface having a plurality of contacts, the through holes containing a conductive material therein electrically connected to the plurality of contacts. The plurality of electrodes are disposed on the first surface and electrically connected to the plurality of contacts on the second surface via the conductive material in the plurality of through holes. The electronic device is disposed on the second surface and electrically connected to the contacts on the second surface. The electrolyte receiving space has an electrolyte therein and is adjacent to the first surface, allowing the plurality of electrodes to contact the electrolyte.

[0009] In one embodiment, the electrodes include at least an anode and a cathode. The electrodes may further include a reference electrode. The electrodes may further include a redundant electrode.

[0010] In one embodiment, any of the electrodes is electrically connected to multiple contacts through multiple through holes.

[0011] In one embodiment, the first surface is coated with a hydrophilic layer.

[0012] In one embodiment, the electrolyte-receiving space is formed by attaching a highly absorbent material to the first surface.

[0013] In one embodiment, the highly absorbent material is a sponge.

[0014] In one embodiment, the highly absorbent material is polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylic acid, polylactic acid (PLA), polyglycolic acid (PGA), PLA / PGA copolymers, polycaprolactone (PCL), and polymeric fiber products made from the aforementioned materials.

[0015] In one embodiment, the electrolyte-containing space is formed by attaching a breathable film to the first surface, the electrolyte-containing space being sealed with the breathable film.

[0016] In one embodiment, the electronic device includes a circuit board, an input terminal, and an output terminal.

[0017] In one embodiment, the circuit board is electrically connected to the electrochemical pump board by the output terminal, and one end of the input terminal is electrically connected to the circuit board and the other end is an input port of the power supply.

[0018] In one embodiment, the electronic device further includes drive circuitry.

[0019] In one embodiment, the electronic device includes a power source.

[0020] In one embodiment, the circuit board is electrically connected to the contacts by the output terminals, the power source is electrically connected to the circuit board via the input terminals, and the drive circuitry is electrically connected to the circuit board and electrically connected to the power source.

[0021] In one embodiment, the electronic device is removable.

[0022] In another aspect of the present disclosure, a drug delivery device is provided. The drug delivery device includes a container having a first opening and a second opening facing each other for containing a drug, an isolation member, and an electrochemical pump, the first opening being a delivery outlet for the drug. The isolation member is disposed within the container between the two openings and can slide freely along the wall of the container. The electrochemical pump is disposed at the second opening, and the electrochemical pump and the container are tightly coupled to seal the second opening.

[0023] In one embodiment, the container is a syringe, and the syringe can further include a needle disposed in the first opening.

[0024] In one embodiment, the container is transparent or translucent.

[0025] In one embodiment, the container is rigid or flexible.

[0026] In one embodiment, the isolation member comprises a rubber plug. [Brief description of the drawings]

[0027] [Figure 1] Schematic diagram of an electrochemical pump according to the present disclosure. [Diagram 2] 1 is a cross-sectional view of a drug delivery device according to the present disclosure; [Diagram 3] A diagram showing the relationship between the flow rate of an electrochemical pump and the number of through-holes. [Figure 4] Figure 1 shows the relationship between the total delivery volume of the electrochemical pump and the number of through-holes. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0028] All technical and scientific terms used in the present specification and claims have definitions known to those skilled in the art to which the present invention belongs, unless otherwise defined. The singular forms "a", "an", "the", etc. include plural referents unless otherwise clearly stated in the context. As used herein, "or" or "and" means "and / or" unless otherwise stated. Furthermore, the terms "comprising" and "including" are non-limiting open-ended conjunctions. The above definitions are only illustrative references for the definition of terms and should not be construed as limiting the present invention. Unless otherwise specified, the materials used in the present invention are commercially available and readily available.

[0029] Ordinal numbers such as "first," "second," and the like used in the specification and claims are intended only to describe the elements described and do not imply or indicate an order of execution between the elements described, or an order between one element and another element, or an order between steps in a manufacturing process. These ordinal numbers are merely used to distinguish an element having a certain name from another element having the same name.

[0030] Furthermore, as used herein, terms such as "on," "above," and "over" do not only refer to direct contact between an element and another element (e.g., a substrate), but also include indirect contact between an element and another element (e.g., a substrate).

[0031] (Example) 1, an electrochemical pump 10 is provided. The electrochemical pump 10 includes a substrate 101, an electrolyte containing space 102, a plurality of electrodes 103, and an electronic device 104.

[0032] The substrate 101 includes a first surface 1011, a second surface 1012, a plurality of through holes 1013, a plurality of conductive materials 1014, and a plurality of contacts 1015. The contacts 1015 are disposed on the side of the through holes 1013 that faces the second surface 1012, and the conductive materials 1014 are disposed in the through holes 1013. Therefore, components on the first surface 1011 and components on the second surface 1012 can be electrically connected. The electrolyte containing space 102 is disposed on the first surface 1011, and an electrolyte 1021 is contained therein. The electrode 103 is disposed on the first surface 1011, in direct contact with the electrolyte 1021, and electrically connected to the conductive materials 1014 in the through holes 1013. The electronic device 104 is disposed on the second surface 1012, and electrically connected to the contacts 1015.

[0033] According to the present disclosure, both sides of the through-hole 1013 can be electrically connected by, but not limited to, filling the through-hole 1013 with a conductive material, coating the wall of the through-hole 1013 with a conductive material layer, or inserting a conductive lead into the through-hole 1013. According to the present invention, the through-hole 1013 and the conductive material 1014 therein can be obtained using a feedthrough technique. The feedthrough technique is widely applied in the manufacture of complementary metal oxide semiconductor (CMOS) processes and integrated circuit (IC) packaging. This can completely isolate the "wet" structures (i.e., various structures at a first surface that are directly connected to the electrolyte) from the "dry" structures (i.e., various structures at a second surface that are directly connected to the surface, such as electronic devices), avoiding direct contact between the electrolyte and the electronic devices, and improving the reliability of the entire device.

[0034] In one embodiment, the contacts 1015 are a plurality of contact pads.

[0035] According to the present disclosure, the electrolyte-containing space 102 for containing the electrolyte is constructed by attaching a superabsorbent material to the first surface or by attaching a breathable film to the first surface. In one embodiment, the electrolyte-containing space 102 is a superabsorbent material coated on the first surface 1011, which can form the electrolyte 1021 into a gel-like state, maintaining contact between the electrode 103 and the electrolyte 1021, preventing electrolyte leakage, and allowing the generated gas to leave the electrolyte-containing space 102. The electrolyte 1021 can be a solution that can generate gas through the electrode, such as, but not limited to, water or an electrolyte solution.

[0036] In a preferred embodiment, the highly absorbent material is a sponge. In another embodiment, the highly absorbent material is attached to the surface of the electrode 103. The highly absorbent material is made of a material selected from the group consisting of polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylic acid, polylactic acid (PLA), polyglycolic acid (PGA), PLA / PGA copolymer, and polycaprolactone (PCL).

[0037] In a preferred embodiment, the number of electrodes 103 is at least three. More specifically, two electrodes 103 function as anodes and cathodes, respectively. To obtain better electrochemical performance, the anodes and cathodes are arranged alternately to form an interdigitated electrode structure. The other electrode is a reference electrode to avoid voltage drops, for example, voltage drops due to ohmic voltages generated by current flow in dilute acid solutions, salt water plasma electrolytes. Voltage drops may affect the accuracy of drug delivery, so it is necessary to avoid voltage drops to obtain accurate voltage level measurements. If there are four or more electrodes, the remaining electrodes are redundant electrodes. By providing these redundant electrodes, the inconvenience of repairing suddenly broken electrodes can be avoided.

[0038] To improve the electrochemical efficiency, any electrode 103 can be electrically connected to the electronic device 104 through multiple through holes 1013. In a preferred embodiment, the anode and cathode each contain 20 through holes. Figures 3 and 4 show a comparison of the electrochemical efficiency of the electrodes with this configuration and other designs. The design with 20 anode and cathode each (electrodes and contact pads are located on opposite sides, and 40 through holes) has about a 30% increase in flow rate and total delivery volume compared to the design with no through holes (electrodes and contact pads are located on the same side). Also, the design with one anode and one cathode each (electrodes and contact pads are located on opposite sides, and 2 through holes) has about a 20% increase in flow rate and total delivery volume compared to the design with one anode and one cathode each (electrodes and contact pads are located on opposite sides, and 2 through holes).

[0039] To improve electrochemical efficiency, the first surface 1011 and the electrode 103 can be coated with a hydrophilic layer. Coating materials can include, but are not limited to, polyvinylphenol (PVP), polyacrylic acid (PAA), poly(vinylphenol), ethylene oxide (PEO), polysaccharides, proton exchange membranes (e.g., sulfonated tetrafluoroethylene, also known as Nafion), nanostructured metals, epoxy resins, and polymeric textiles made from the aforementioned materials.

[0040] The coated hydrophilic layer is used to ensure that the first surface 1011 of the electrochemical pump 10 is hydrophilic and can continuously produce gas during the electrochemical reaction. The coated electrode can provide higher gas solubility compared to conventional untreated electrodes.

[0041] To further increase the electrochemical efficiency, it is effective to change the geometric shape of the electrodes. In some embodiments, the inverted trapezoid electrodes are fabricated by an improved standard electron beam lithography program or an improved photolithography program with an improved oxygen plasma treatment, an improved reactive ion etching (RIE), an improved deep reactive ion etching (DRIE), or an improved inductively coupled plasma (ICP). Meanwhile, the electrochemical efficiency can be increased by changing the shape of the electrodes. In one embodiment, the electrode 103 is fabricated in an inverted trapezoid shape to generate a stronger electric field and generate a larger amount of gas. In another embodiment, the hydrophilicity of the electrochemical pump 10 can be achieved by hydrophilic treatment, such as an oxygen plasma process, chemical etching, and mechanical friction.

[0042] Electronic device 104 is electrically connected to contacts 1015 and is used to power electrodes 103 and to control the time and power of the electrochemical reactions. In a preferred embodiment, electronic device 104 is removable and can be assembled with or separated from other components of electrochemical pump 10.

[0043] In one embodiment, the electronic device 104 includes a circuit board 1041 , an input terminal 1042 , and an output terminal 1043 .

[0044] The output terminal 1043 electrically connects the circuit board 1041 to the contacts 1015 to control the electrodes 103 and thus the electrochemical pump 10 to produce gas. The input terminal 1042 is electrically connected at one end to the circuit board 1041 and at the other end to a power source to provide power to the electrochemical pump 10. The power source may be an external power source or may be contained within the electronic device 104.

[0045] In one embodiment, the electronic device 104 further includes a power source 1044 that is electrically connected to the input terminal 1042 .

[0046] In a preferred embodiment, the electronic device 104 further comprises drive circuitry to control the activation and deactivation of the electronic device 104 .

[0047] Thus, the output terminal 1043 serves as an electrical bridge between the electronic device 104 and other components of the electrochemical pump 10. The output terminal 1043 may be a microconnector, such as a pogo pin.

[0048] As shown in FIG. 2, the present disclosure provides a drug delivery device 200, which includes a container, for example a syringe 20, and an electrochemical pump 10.

[0049] The syringe 20 includes a first opening 21, a second opening 22, and an isolating member 23. The first opening 21 and the second opening 22 face each other.

[0050] In a preferred embodiment, the syringe 20 further includes an injection needle 24 disposed in the first opening 21 .

[0051] In one embodiment, drug delivery device 100 is small enough to deliver very small amounts of drug, with syringe 10 having a volume preferably in the microliter (μL) range (0.1 to 500 microliters).

[0052] In another embodiment, the drug delivery device 100 is capable of delivering high concentration, large volume drugs, with the volume of the syringe 20 preferably being in the milliliter (mL) range (0.1 to 500 mL).

[0053] According to one embodiment of the present invention, the isolating member 23 is disposed inside the syringe 20 and divides the syringe 20 into a first chamber 201 and a second chamber 202. The first chamber 201 is used to contain a drug, and the second chamber 202 is used to contain the electrolyte-containing space 102 of the electrochemical pump and the electrolyte 1021 therein.

[0054] According to one embodiment of the invention, the container may be a syringe 20 and may be made of a transparent or translucent material. The container, such as a syringe, may be rigid or flexible. Preferably, the syringe 20 is made of a rigid material, which may include, but is not limited to, glass (e.g., quartz, fused silica, alkali lime, silicates, borosilicates, etc.), polymers / plastics (e.g., polycarbonate (PC), polymethyl methacrylate (PMMA), polypropylene (PP), polyethylene (PE), ethylene terephthalate (PET), polylactic acid (PLA), thermoplastic elastomers (TPE), and parylene, COP or COC cyclic olefin polymers, etc.), rubbers (natural rubber and rubber), colloids (epoxy resins, silicones, and acrylic resins), and conductive polymers (polyfluorenes, polybiphenyl compounds, polypyrene, polyazulene, polynaphthalene, polypyrrole (PPY), polyaniline (PANI), polythiophenes (PT), poly(3,4-ethylenedioxythiophene) (PEDOT), polyparaphenylene sulfide (PPS), polyacetylene (PAC), and polyphenylene vinylene (PPV)).

[0055] In this embodiment, the isolation member 23 is a diaphragm. The isolation member 23 can be made of, but is not limited to, a thermoplastic elastomer (TPE), a styrene-ethylene-butylene-styrene block copolymer (SEBS), a styrene-ethylene-propylene-styrene block copolymer (SEPS), polyparaethylene, etc. However, in another embodiment, the isolation member 23 can be a blocking member made of a rubber plug, which can be made of a material such as rubber, polytetrafluoroethylene (Teflon), silicone, a thermoplastic elastomer (TPE), a styrene-ethylene-butylene-styrene block copolymer (SEBS), a styrene-ethylene-propylene-styrene block copolymer (SEPS), and parylene.

[0056] According to the present disclosure, the electrochemical pump 10 is disposed at the second opening 22 of the syringe 20, and the electrochemical pump 10 and the syringe 20 are tightly coupled to seal the second opening 22. This can prevent leakage of the electrolyte 1021 contained therein and the gas generated by the electrochemical pump 10. Thus, when the electrolyte 1021 undergoes an electrochemical reaction to generate gas, the pressure in the second chamber 202 becomes higher than the pressure in the first chamber 201, and the isolating member 23 moves toward the first opening 21, and the drug is delivered. Thus, the isolating member 23 is disposed to isolate the first chamber 201 and the second chamber 202 from each other to prevent the electrolyte and the drug from mixing. Methods of sealing include, but are not limited to, using a gasket (e.g., an O-ring, etc.), using an adhesive seal, or using welding (e.g., ultrasonic, heat, or laser welding, etc.).

[0057] In one embodiment, after the second opening 22 is sealed, the electrochemical pump 10 is removable.

[0058] In another embodiment, after the second opening 22 is sealed, the electrochemical pump 10 is not removable.

[0059] It will be apparent to those skilled in the art that the embodiments disclosed herein are illustrative and not limiting. Those skilled in the art can implement the present invention through many modifications or substitutions without departing from the technical features of the present invention. According to the embodiments described herein, the present invention can be modified in various ways without interfering with the implementation of the present invention. The claims set forth below define the scope of the present invention and cover the above-mentioned methods and structures, as well as their equivalents. [Explanation of symbols]

[0060] 10 Electrochemical Pump 101 Substrate 1011 First Surface 1012 Second Surface 1013 through hole 1014 Conductive materials 1015 Contact 102 Electrolyte storage space 1021 Electrolyte 103 Electrode 104 Electronic Devices 1041 Circuit Board 1042 Input terminal 1043 Output terminal 1044 Power supply 200 Drug delivery device 20 Syringe 201 Chamber 1 202 Chamber 2 21 First opening 22 Second opening 23 Isolation member 24 Syringe needle

Claims

1. 1. An electrochemical pump comprising: a substrate including a first surface, a second surface, and a plurality of through holes, the second surface having a plurality of contacts, the through holes including a conductive material therein and electrically connected to the plurality of contacts; a plurality of electrodes disposed on the first surface and electrically connected to a plurality of the contacts on the second surface via the conductive material within the plurality of the through holes; an electronic device disposed on the second surface and electrically connected to the contacts on the second surface; an electrolyte-containing space containing an electrolyte therein and adjacent to the first surface such that the plurality of electrodes are in contact with the electrolyte; Equipped with Electrochemical pump.

2. The electrodes include at least an anode and a cathode.

2. The electrochemical pump of claim 1.

3. The electrodes further include a reference electrode.

3. The electrochemical pump of claim 2.

4. The electrodes further include redundant electrodes.

3. The electrochemical pump of claim 2.

5. Any of the electrodes is electrically connected to a plurality of the contacts via a plurality of the through holes.

2. The electrochemical pump of claim 1.

6. the first surface is coated with a hydrophilic layer; 2. The electrochemical pump of claim 1.

7. The electrolyte-containing space is configured by attaching a highly absorbent material to a first surface.

2. The electrochemical pump of claim 1.

8. The highly absorbent material is a sponge.

8. An electrochemical pump according to claim 7.

9. The highly absorbent material is made of a material selected from the group consisting of polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylic acid, polylactic acid (PLA), polyglycolic acid (PGA), PLA / PGA copolymer, polycaprolactone (PCL), and polymeric textiles made from these materials; 8. An electrochemical pump according to claim 7.

10. the electrolyte-containing space is defined by attaching a breathable film to the first surface; The electrolyte storage space is sealed with the breathable film.

2. The electrochemical pump of claim 1.

11. The electronic device includes a circuit board, an input terminal, and an output terminal.

2. The electrochemical pump of claim 1.

12. The electronic device further includes driving circuitry.

12. An electrochemical pump according to claim 11.

13. the electronic device includes a power source; 13. An electrochemical pump according to claim 12.

14. the output terminal electrically connects the circuit board to the contact; the power supply is electrically connected to the circuit board via the input terminal; the drive circuit component is electrically connected to the circuit board and to the power source; 14. An electrochemical pump according to claim 13.

15. The electronic device is removable.

2. The electrochemical pump of claim 1.

16. 1. A drug delivery device comprising: a container for containing a drug, the container having a first opening and a second opening opposed to each other, the first opening being a drug delivery outlet; an isolating member disposed within the container between the first opening and the second opening, the isolating member being freely slidable along a wall of the container; the electrochemical pump of claim 1 , disposed at the second opening and tightly coupled to the container so as to seal the second opening; Equipped with Drug delivery devices.

17. 17. The drug delivery device of claim 16, wherein the container is a syringe.

18. The syringe includes a needle disposed in the first opening.

18. The drug delivery device of claim 17.

19. 17. The drug delivery device of claim 16, wherein the container is transparent or translucent.

20. 17. The drug delivery device of claim 16, wherein the reservoir is rigid or flexible.

21. The isolating member is made of a rubber plug.

17. The drug delivery device of claim 16.

Citation Information

Patent Citations

  • Gas-driven infusion device with threshold valve at drug outlet

    JP2003500300A

  • Precision flow control within drug pump devices

    JP2015502785A

  • Micro Delivery Device

    JP2019536587A

  • Device for dispensing a liquid particularly useful for delivering medicaments at a predetermined rate

    US5062834A

  • Electrochemical actuator and method of making same

    US5671905A